BCM
CLB icon

Brookstone Capital Management’s Core Laboratories CLB Stock Holding History

Brookstone Capital Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-333
Closed -$38K – 1997
2015
Q2 		$38K Buy
+333
New +$40.4K ﹤0.01% 576

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 16.04% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brookstone Capital Management's CLB Position: Q3 2015 in Review

Brookstone Capital Management sold out of Core Laboratories (CLB) in Q3 2015, closing a stake of 333 shares — an estimated $38K sold.

Brookstone Capital Management first reported a position in CLB in Q2 2015 and held it in 1 quarter. The position peaked at $38K in Q2 2015. 352 funds tracked by Wall St. Rank hold CLB as of Q3 2015.

  • Brookstone Capital Management reported no remaining Core Laboratories position as of Q3 2015 after selling out during the quarter.
  • Brookstone Capital Management sold 333 Core Laboratories shares in Q3 2015, an estimated $38K.
  • Brookstone Capital Management first reported a position in Core Laboratories in Q2 2015 and held it in 1 quarter.
  • Brookstone Capital Management's Core Laboratories position peaked at $38K in Q2 2015.
  • 352 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2015.

Based on Brookstone Capital Management's 13F filing for Q3 2015, filed 28 Oct 2015.